Pharmaceuticals industry
-
Evgen wants to raise up to £20m for clinical studies of experimental Sulforadex tablet to treat brain haemorrhage, prostate and breast cancer
-
Locals will consider Grünenthal employees unwelcome until victims receive compensation from the pharmaceutical company
-
Glybera, a treatment for rare genetic condition lipoprotein lipase deficiency LPLD, undergoing benefits assessment by authorities
-
UK group hopes to get up to 10 drugs approved in next two years as date approaches when US rival could return with a bid
-
Cartoon Kipper Williams on Botox
Kipper WilliamsBotox firm accepts white knight bid
-
-
Deal could allow company to see off a hostile takeover from Canada’s Valeant Pharmaceuticals
-
Netherlands-based Access to Medicine Foundation praises ‘big pharma’ efforts to improve availability of medicines
-
Tom Ireland visits the UK’s only licensed cannabis farm and meets the man responsible for breeding a plant that might be of benefit to millions
-
Newly exposed files show how victims were betrayed by political interference in trial – and how the pill has remained on sale
-
Anne Perkins: First thoughts: By guaranteeing prices to drugs companies, the fund sustains inflated costs to the NHS and the profitability of big pharma
-
Antony Loewenstein: NGOs with months of front line exposure were shunned in favour of a private company which was awarded a $20m contract to run an ebola response in Sierra Leone
-
US drugmaker had wanted to use acquisition of AstraZeneca to shift tax base to Britain, a move known as tax inversion
-
An international investigation into tax deals struck with Luxembourg has uncovered the multi-billion dollar tax secrets of multinationals. Investigative journalist Simon Bowers answered your questions
-
-
Leaked documents show that one of the EU’s smallest states helped multinationals save millions in tax, to the detriment of its neighbours and allies
-
Has Shire stayed on the right side of the PM’s definition of ‘aggressive’ tax avoidance? The public accounts committee may be the right body to find out
-
Ebola is a growing crisis, and companies are profiting by producing safety gear and pharmaceuticals. But if you buy their stocks, are you a good person or a bad one, asks Olga Oksman
-
If traders swap privileged information, they are skewing the odds even more heavily in their favour
-
Turbulent six-year reign of first non-French CEO st Sanofi listed, France’s second biggest company, ended in sacking
-
Share price falls after French pharmaceutical’s board sacks CEO amid row over management style
-
Australia’s trade minister says the Trans-Pacific Partnership free trade deal should be concluded by the year’s end
-
Pharmaceuticals group says ViiV Healthcare could be worth more than Marks & Spencer or Sainsbury’s if allowed to stand alone
-
-
Island state still grows almost 50% of the world’s pharmaceutical opium poppies, but major factory will move to Victoria to avoid ban on crop imports
-
Giles Fraser: Loose canon: If everyone were healthy, it would be the job of the pharmaceutical companies to persuade us that we were not well
-
Secret negotiations over the Trans Pacific Partnership have been apparently revealed, and experts are concerned about what they show
-
Pharmaceutical takeover is the biggest to be scuttled by the White House’s clampdown on so-called tax inversions
-
The news triggered a sell-off in UK pharmaceutical shares
-
More than £8bn wiped off drug-maker’s market value and follows moves by US Treasury to clamp down on tax inversion deals
-
GPs say the No Advertising Please campaign will help curb the inappropriate prescription of medication
-
Van Badham: I was reluctant to try medication, and it once granted me much-needed relief from depression. But of course, there is no such thing as a ‘one size fit all’ approach to mental health
-
-
Researchers say benefits of antiviral drugs may have been inflated by studies paid for by pharmaceutical companies
-
Research into tropical diseases is chronically neglected – but the horror of this epidemic could transform the battle against hidden killers
-
From curbing the British army’s use of torture in Ireland to ending bans on homosexuality, the court has shaped UK law
-
Drugmaker Roche says £43,000-a-year treatment can extend lives of women with aggressive form of disease
-
Pfizer’s £69bn takeover bid undervalued UK drug firm’s prospects, says Neil Woodford, as he anticipates fresh offer
Nils Pratley on finance Some reasons why Pfizer won’t bid for AstraZeneca again